Integrating network pharmacology and experimental validation to explore the pharmacological mechanism of Astragaloside IV in alleviating urotensin II-mediated renal tubular epithelial cell injury

• Wenyuan Liu ,

  Contributed equally to this work with: Wenyuan Liu, Qianwei Liu

  Roles Conceptualization, Funding acquisition, Writing – review & editing

  Affiliation Department of Nephrology, The First Hospital, Shanxi Medical University, Taiyuan, Shanxi, China

  ⨯
• Qianwei Liu ,

  Contributed equally to this work with: Wenyuan Liu, Qianwei Liu

  Roles Conceptualization, Data curation, Investigation

  Affiliations Shanxi Medical University, Taiyuan, Shanxi, China, Department of Nephrology, Beijing Daxing District People’s Hospital, Daxing, Beijing, China

  ⨯
• Ziyuan Zhang,

  Roles Data curation

  Affiliation Department of Nephrology, The First Hospital, Shanxi Medical University, Taiyuan, Shanxi, China

  ⨯
• Yaling Hu,

  Roles Data curation

  Affiliation Department of Nephrology, The First Hospital, Shanxi Medical University, Taiyuan, Shanxi, China

  ⨯
• Jingai Fang

  Roles Writing – review & editing

  * E-mail: fja3455001@126.com

  Affiliation Department of Nephrology, The First Hospital, Shanxi Medical University, Taiyuan, Shanxi, China

  https://orcid.org/0009-0002-2084-8781

  ⨯